Baxter International Inc. (BAX) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Baxter International Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Short-term debt | |
|
|
|
|
|
Current maturities of long-term debt and lease obligations | |
|
|
|
|
|
Accounts payable, principally trade | |
|
|
|
|
|
Income taxes payable | |
|
|
|
|
|
Deferred income taxes | |
|
|
|
|
|
Common stock dividends payable | |
|
|
|
|
|
Employee compensation and withholdings | |
|
|
|
|
|
Property, payroll and certain other taxes | |
|
|
|
|
|
Infusion pump reserves | |
|
|
|
|
|
Business optimization reserves | |
|
|
|
|
|
Accrued rebates | |
|
|
|
|
|
Other | |
|
|
|
|
|
Accounts payable and accrued liabilities | % |
% |
% |
% |
% |
|
Current liabilities | % |
% |
% |
% |
% |
|
Long-term debt and lease obligations, excluding current maturities | |
|
|
|
|
|
Pension and other employee benefits | |
|
|
|
|
|
Litigation reserves | |
|
|
|
|
|
Infusion pump reserves | |
|
|
|
|
|
Business optimization reserves | |
|
|
|
|
|
Other | |
|
|
|
|
|
Other long-term liabilities | % |
% |
% |
% |
% |
|
Long-term liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Common stock, $1 par value | |
|
|
|
|
|
Common stock in treasury, at cost | |
|
|
|
|
|
Additional contributed capital | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Accumulated other comprehensive loss | |
|
|
|
|
|
Baxter International Inc. (Baxter) shareholders’ equity | % |
% |
% |
% |
% |
|
Noncontrolling interests | |
|
|
|
|
|
Total equity | % |
% |
% |
% |
% |
|
Total liabilities and equity | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center